Global Ancylostomiasis Treatment Market, By Treatment (Anthelminthic Drugs, Blood Transfusion, Others), Diagnosis (Serologic Tests, Physical Examination, Ova and parasites stool test, Microscopic Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), Symptoms (Abdominal pain, Anaemia, Diarrhea, Dyspepsia, Intestinal Bleeding, Eosinophilia, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Ancylostomiasis Treatment Market
Ancylostomiasis treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 4.20% in the above mentioned forecast period.
Ancylostomiasis is a rare parasitic disease which is caused due to the Ancylostoma hookworms. These worm larvae transmitted to the human body when the broken skin on the feet comes in the contact with the contaminated soil. They travel via bloodstream to the lungs and intestine and begin to multiply. Ancylostomiasis is also called hookworm infection. The symptoms of this condition include abdominal pain, anaemia, diarrhea, dyspepsia, intestinal bleeding, eosinophilia and malnutrition.
Rise in the prevalence of ancylostomiasis, growing healthcare expenditure, medical advancement, poor hygiene, growing government funding, rising initiatives by government and private organisations to spread awareness about the rare disease and its preventive measures are the factors that will expand the ancylostomiasis treatment market.
Rise in the research and development activities and ongoing clinical trials markets will provide beneficial opportunities for the ancylostomiasis treatment market in the forecast period of 2021-2028.
However, high cost of treatment and side effects associated with the drugs are the factors that will hinder the market growth. Lack of awareness related to the preventive measures of ancylostomiasis will challenge the ancylostomiasis treatment market in the forecast period mentioned above.
This ancylostomiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ancylostomiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Ancylostomiasis Treatment Market Scope and Market Size
The ancylostomiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of treatment, the ancylostomiasis treatment market is segmented into anthelminthic drugs, blood transfusion and others. Anthelminthic drugs are further sub-segmented into albendazole, mebendazole and pyrantel pamoate.
- On the basis of diagnosis, the ancylostomiasis treatment market is segmented into serologic tests, physical examination, ova and parasites stool test, microscopic examination and others.
- On the basis of dosage, the ancylostomiasis treatment market is segmented into tablet, injection and others.
- On the basis of route of administration, the ancylostomiasis treatment market is segmented into oral, intravenous and others.
- On the basis of symptoms, the ancylostomiasis treatment market is segmented into abdominal pain, anaemia, diarrhea, dyspepsia, intestinal bleeding, eosinophilia and others.
- On the basis of end-users, the ancylostomiasis treatment market is segmented into clinic, hospital and others.
The ancylostomiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Ancylostomiasis Treatment Market Country Level Analysis
Ancylostomiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.
The countries covered in the ancylostomiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the ancylostomiasis treatment market due to the presence of major key players, growing investment for R&D activities and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare infrastructure and growing disposable income.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Ancylostomiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Ancylostomiasis Treatment Market Share Analysis
Ancylostomiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to ancylostomiasis treatment market research.
The major players covered in the ancylostomiasis treatment market report are Cipla Inc., Johnson & Johnson Private Limited, Mankind Pharma, Sun Pharmaceutical Industries Ltd., Merck KGaA, Amneal Pharmaceuticals LLC., Boehringer Ingelheim International GmbH., Zoetis, Merck Sharp & Dohme Corp., Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, SeQuent, Lasa Supergenerics Ltd., K.A.Malle Pharmaceuticals, LEO BIO-CARE PVT. LTD., Salius Pharma Private Limited., Fredun Group, Hubei Zhongjia-Chem Pharmaceutical Co., Ltd., Ashish Life Science, AdvaCare Pharma, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-